DI
GILD icon

Disciplined Investors’s Gilead Sciences GILD Stock Holding History

Disciplined Investors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Sell
3,046
-11
-0.4% -$1.45K 0.19% 99
2026
Q1 		$426K Buy
3,057
+18
+0.6% +$2.52K 0.25% 80
2025
Q4 		$373K Buy
3,039
+107
+4% +$13K 0.24% 77
2025
Q3 		$325K Sell
2,932
-90
-3% -$10.2K 0.23% 88
2025
Q2 		$335K Buy
3,022
+23
+0.8% +$2.45K 0.26% 80
2025
Q1 		$336K Buy
2,999
+10
+0.3% +$1.03K 0.3% 71
2024
Q4 		$269K Buy
+2,989
New +$269K 0.26% 89

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Disciplined Investors's GILD Position: Q2 2026 in Review

Disciplined Investors reduced its Gilead Sciences (GILD) stake by 0.36% in Q2 2026, selling an estimated $1.45K and leaving 3,046 shares worth $385K. The position accounts for 0.19% of the portfolio, ranked #99.

Disciplined Investors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $426K in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Disciplined Investors held 3,046 shares of Gilead Sciences worth $385K as of Q2 2026.
  • Disciplined Investors sold 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
  • Gilead Sciences made up 0.19% of Disciplined Investors's portfolio in Q2 2026, its #99 holding.
  • Disciplined Investors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Disciplined Investors's Gilead Sciences position peaked at $426K in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Disciplined Investors's 13F filing for Q2 2026, filed 11 Aug 2026.